Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Folic acid

This article was originally published in The Tan Sheet

Executive Summary

Small increments in nutrient intake have dose-dependent effect on homocysteine reduction, Australian researchers report at American College of Cardiology Annual Scientific Session in Orlando, Fla. March 18-21. Bruce Neal, et al., Institute for International Health, Sydney, studied effects of .2 mg and 2 mg doses of folic acid on plasma homocysteine in a double-blind, placebo-controlled, randomized trial of 723 individuals with history of MI or unstable angina. "Compared to placebo, 2 mg folic acid reduced homocysteine by 1.7 mmol/L and .2 mg reduced homocysteine by 1.2 mmol/L," Neal et al. report, noting effects of both doses "were significantly greater among those with higher homocysteine levels or lower red blood cell folate levels at entry"
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS092370

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel